Advantage Partners and LYFE Capital completed the acquisition of 72.80% stake in Nihon Chouzai for JPY100bn.

Advantage Partners, a private equity investment firm in Japan, and LYFE Capital, a healthcare-focused private equity company, completed the acquisition of 72.80%% stake in Nihon Chouzai, a pharmaceutical company that offers medical insurance, online medicine, and health consultation services, for JPY100bn.